AUS
NZ
UK
CA
USA
IND
Healthcare
What Keeps Merck At The Center Of Global Healthcare Innovation?
June 02, 2026 12:05 AM PDT| By Anmol KhazanchiMerck continues attracting attention through its pharmaceutical research, vaccine portfolio, oncology activities, and broad participation in global healthcare markets.
Top US Health Insurance Stocks In S&P 500
June 01, 2026 05:38 PM PDT| By Anmol KhazanchiUS health insurance stocks continue to navigate medical cost pressure, Medicare Advantage challenges, regulatory changes, and evolving care models, while major managed care companies remain central to the U.S. healthcare landscape.
Top US Big Pharma Stocks Shaping Healthcare’s Next Era
June 01, 2026 01:15 PM PDT| By Anmol KhazanchiMajor pharmaceutical companies continue driving healthcare innovation through drug development, expanding therapeutic portfolios, and strategic acquisitions while navigating patent expirations, pricing pressures, and evolving regulatory frameworks.
Why Is S&P 500 Attention on Revvity After Earnings Miss?
June 01, 2026 09:42 AM PDT| By Anmol KhazanchiRevvity drew attention through earnings developments, research tools, laboratory innovation, diagnostic technologies, and broader life sciences trends shaping the S&P 500 Index.
Why Did NYSE Composite Investors Track GSK Voting Rights Update?
June 01, 2026 09:16 AM PDT| By Anmol KhazanchiGSK released a voting rights update detailing share capital structure, treasury shares, regulatory disclosures, and corporate governance transparency across NYSE Composite companies.
Why Is NYSE Composite Spotlighting AMN’s Strong Earnings Growth?
June 01, 2026 09:00 AM PDT| By Anmol KhazanchiAMN Healthcare Services remained in focus following quarterly results as healthcare staffing, workforce technology, and broader healthcare services activity influenced NYSE Composite performance.
Why Pfizer's Oncology Strategy Is Drawing Renewed Attention
June 01, 2026 12:20 AM PDT| By Anmol KhazanchiPfizer continues attracting attention as oncology research, strategic collaborations, and clinical development activities influence the global pharmaceutical industry.
Can S&P 500 Access Expansion Drive Eli Lilly Obesity Growth?
May 31, 2026 08:46 AM PDT| By Anmol KhazanchiEli Lilly’s expanding obesity treatment access, clinical research activity, and healthcare coverage developments highlight evolving pharmaceutical sector dynamics within the S&P 500 Index.
Microbot Medical Draws Attention Amid Healthcare Stock Growth
May 30, 2026 11:40 AM PDT| By Anmol KhazanchiMicrobot Medical continues advancing medical robotics innovation with strong cash reserves and a lengthy operational runway. The company's financial flexibility supports ongoing development efforts within the evolving healthcare technology sector.
Novo Nordisk Valuation Story Deepens After Recent Stock Moves
May 30, 2026 11:34 AM PDT| By Anmol KhazanchiNovo Nordisk remains in focus as mixed share returns, strong earnings signals, GLP medicine demand, valuation debate, and pricing concerns shape market attention.
Big Biotech Leaders With Established Therapy Strength
May 29, 2026 03:06 PM PDT| By Anmol KhazanchiBig biotech leaders continue anchoring healthcare through established therapies, specialized treatment areas, resilient patient demand and research pipelines that shape future disease-care relevance across major markets.
Is STERIS Valuation Reset Opening A New Debate?
May 29, 2026 12:17 PM PDT| By Anmol KhazanchiHealthcare valuation debate has intensified as recent weakness meets recurring demand, margin visibility, cost pressure and premium multiple questions across essential medical services and sterilization markets.
Eli Lilly Gains Momentum as Weight-Loss Drug Access Expands
May 29, 2026 11:33 AM PDT| By Anmol KhazanchiHealthcare access remains a critical factor within obesity treatment markets as expanded coverage supports broader patient availability, strengthens treatment adoption pathways and highlights evolving dynamics across pharmaceutical innovation.
Bruker Momentum Builds Across Life Sciences Tools Market
May 29, 2026 07:36 AM PDT| By Anmol KhazanchiBruker gained attention after stronger quarterly results, resilient scientific instrument demand, and broader research tools momentum supported by life sciences innovation and laboratory automation trends.
Why S&P 500 Index Healthcare Stocks Driving Medical Devices?
May 28, 2026 10:15 PM PDT| By Anmol KhazanchiHealthcare Stocks including Intuitive Surgical, Stryker, and Boston Scientific operate across robotic surgery, orthopaedics, and cardiovascular devices amid evolving healthcare technology demand.
Three Pharma Giants Driving the Obesity Drug Boom
May 28, 2026 03:38 PM PDT| By Anmol KhazanchiObesity and metabolic drugs have reshaped pharma. Three US-listed names span the leaders and challengers in a market with vast potential and intensifying competition.
Bruker Shares Surge Following Strong (NASDAQ:BRKR) And Analyst Revisions
May 28, 2026 01:30 PM PDT| By Anmol KhazanchiBruker shares moved sharply higher after stronger earnings, upbeat analyst sentiment, and growing attention toward scientific research and laboratory technology demand.
Why Eli Lilly’s Latest Healthcare Move Is Drawing Attention?
May 28, 2026 01:16 PM PDT| By Anmol KhazanchiEli Lilly remains in focus as obesity drug access, oral treatment progress, clinical updates, and manufacturing expansion strengthen its long-term pharmaceutical growth narrative.
Agilent Technologies Momentum Lifts Market Confidence
May 28, 2026 12:59 PM PDT| By Anmol KhazanchiAgilent Technologies remains in focus as stronger analytical instrument demand, operational execution, and expanding scientific technology adoption continue shaping broader market sentiment.
Medical Device Giants Compounding Through Innovation
May 27, 2026 03:25 PM PDT| By Anmol KhazanchiMedical device businesses with established franchises continue to compound through innovation cycles. Three US-listed names span diversified medical technologies with consistent dividend records.
